Corcept Therapeutics (CORT) Work In Process (2012 - 2026)

Corcept Therapeutics has disclosed Work In Process across 15 years of filings, most recently posting $11.8 million for Q1 2026.

• Work In Process for Q1 2026 came in at $11.8 million, up 67.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.8 million (up 67.86% YoY), and the FY2025 annual result was $13.7 million, up 75.93% from the prior year.
• Work In Process came in at $11.8 million for Q1 2026 at Corcept Therapeutics, down from $13.7 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $14.2 million in Q3 2025 to a low of $6.7 million in Q2 2023.
• The 5-year median for Work In Process is $8.5 million (2023), against an average of $9.7 million.
• Across the five-year window, Work In Process tumbled 41.28% in 2023 and jumped 82.86% in 2025, its largest moves.
• Corcept Therapeutics' Work In Process stood at $7.8 million in 2022, then grew by 5.19% to $8.2 million in 2023, then declined by 5.39% to $7.8 million in 2024, then soared by 75.93% to $13.7 million in 2025, then slipped by 13.82% to $11.8 million in 2026.
• The last three Work In Process figures came in at $11.8 million (Q1 2026), $13.7 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.